Many previous studies have demonstrated that the levels of plasma pentraxin-3 were positively related to the severity of sepsis, acute pancreatitis, acute myocardial injury and other diseases, which indicated that pentraxin-3 can serve as a novel biomarker for inflammation, infection and tissue damage [9–14]. This evidence concerns the gene PTX3 and acute pancreatitis.